Janux Therapeutics (JANX) PT Lowered to $23 at Evercore ISI
Tweet
Share
E-mailGet Alerts JANX Hot Sheet
Price: $14.34 +0.84%
Rating Summary:
14 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
14 Buy, 4 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Evercore ISI analyst Jonathan Miller lowered the price target on Janux Therapeutics (NASDAQ: JANX) to $23.00 (from $25.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Regenxbio Inc. (RGNX) PT Raised to $32 at Baird
- Deutsche Bank Downgrades Apogee Therapeutics Inc (APGE) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
